Actively Recruiting

Phase Not Applicable
Age: 7Years - 18Years
All Genders
ID05927389

BONeMOVE: Adapted Physical Activity Program for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta

Led by University Hospital, Toulouse · Updated on 2026-05-08

30

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the effects of a 6-month adapted physical activity program on the endurance of children and adolescents aged 7 to 18 with Osteogenesis Imperfecta (OI), a rare genetic condition causing fragile bones and muscle weakness. The study aims to see if this exercise program can improve maximum oxygen consumption (VO2 peak), endurance, and quality of life by addressing common symptoms such as chronic fatigue and decreased physical function. The intervention involves a personalized training program tailored to each participant's condition and abilities. Assessments will take place over two visits spaced six months apart at the Constitutional Bone Diseases unit. The adapted physical activity program will be shared with participants and their families via videoconference, with regular adjustments made every 15 days through phone calls by an APA coach to support ongoing participation. Participants will undergo evaluations including endurance testing, quality of life questionnaires, step counts, and weight measurements at the start and after six months. Researchers will monitor changes in maximum endurance capacity and other health indicators. The study provides ongoing support and reassessment to help maintain engagement and track progress throughout the six-month period.

CONDITIONS

Brief Title

Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Osteogenesis Imperfecta

Who Can Participate

Age: 7Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed Osteogenesis Imperfecta
  • Informed and written consent signed by at least one parent or guardian
  • Patient affiliated with a social security scheme or equivalent
Not Eligible

You will not qualify if you...

  • Children unable to walk or perform the effort test
  • Pregnant or breastfeeding
  • Participation in other interventional research studies

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Adapted Physical Activity Program

Duration - 6 months

Participants follow a personalized training program adapted to their condition and capacities, developed from their initial assessment.

2 visits spaced 6 months apart and phone calls every 15 days

Trial Site Locations

Total: 2 locations

1

CHU Montpellier Hôpital Arnaud de Villeneuve

Montpellier, France

Not Yet Recruiting

2

CHU Toulouse

Toulouse, France

Actively Recruiting

Loading map...

Research Team

T

Thomas EDOUARD, MD

M

Marjolaine WILLEMS, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Similar Trials

Audio-vestibular Evaluation of Children and Young Adults Wit...

Osteogenesis Imperfecta

Actively Recruiting

1 location

Rare Diseases Clinical Research Network Brittle Bone Disease...

Osteogenesis Imperfecta

Actively Recruiting

12 locations

Effects of Bisphosphonates on Osteogenesis Imperfecta-Relate...

Osteogenesis Imperfecta

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Fatigue and disturbances of sleep in patients with osteogenesis imperfecta - a cross-sectional questionnaire study.

Heidi Arponen, Janna Waltimo-Sirén, Helena Valta...

https://pubmed.ncbi.nlm.nih.gov/29310646